Literature DB >> 265745

Granulocytic sarcoma of the brain.

M Krishnamurthy, N Nusbacher, A Elguezabal, B R Seligman.   

Abstract

An unusual case of granulocytic sarcoma (chloroma) of the parenchyma of the brain occurring in a patient with acute myelocytic leukemia in remission is described and the literature reviewed. The patient presented with an intracranial mass without clinical evidence of meningeal involvement. The value of 99mTc scan in CNS leukemia is shown.

Entities:  

Mesh：

Year:  1977        PMID： 265745     DOI： 10.1002/1097-0142(197704)39:4<1542::aid-cncr2820390427>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  6 in total

1.  Granulocytic sarcoma of the central nervous system: inital presentation of leukemia.

Authors:  J F Llena; K Kawamoto; A Hirano; E H Feiring
Journal:  Acta Neuropathol       Date:  1978-05-24       Impact factor: 17.088

Review 2.  Solitary myeloblastoma presenting as acute hydrocephalus: review of literature, implications for therapy.

Authors:  A A Fruauff; E S Barasch; A Rosenthal
Journal:  Pediatr Radiol       Date:  1988

3.  Myeloblastoma of the brain.

Authors:  T A Simpson; M L Anderson; J H Garcia; J C Barton
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Granulocytic sarcoma (chloroma) of the cerebellum and meninges a case report.

Authors:  J Nickels; A Koivuniemi; O Heiskanen
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

5.  Therapeutic modalities for central nervous system involvement by granulocytic sarcoma (chloroma) in children with acute nonlymphocytic leukemia.

Authors:  Y Takaue; S J Culbert; T Baram; A Cork; J M Trujillo
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

6.  A case of granulocytic sarcoma of the brain in a patient with myelodysplastic syndrome.

Authors:  H S Lee; J W Jeon; J H Kim; T E Park; S K Park; J H Won; S H Baick; D S Hong; H S Park
Journal:  Korean J Intern Med       Date:  1995-07       Impact factor: 2.884
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.